Trial Profile
A Phase I/II Trial of CPT-11 [irinotecan] With Carboplatin in Patients With Glioblastoma Multiforme Prior to Radiation Therapy
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 27 May 2019
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Carboplatin
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 16 Sep 2005 New trial record.